Menstrually Associated Migraine

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-01-02
Clinical Trial Update: A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual Migraine [Phase 3]
A Phase 3 randomized trial evaluating frovatriptan for intermittent prevention of menstrually associated migraine has completed.